동물 장 건강 시장 : 규모, 점유율, 성장률 및 산업 분석, 지역별 동향 예측(2026-2034년)

Growth Factors of animal intestinal health Market

The global animal intestinal health market is experiencing steady growth as livestock producers, feed manufacturers, and animal healthcare companies increasingly focus on improving digestive health, feed efficiency, and disease resistance. According to the report, the global animal intestinal health market size was valued at USD 4.76 billion in 2025. The market is projected to grow from USD 5.16 billion in 2026 to USD 9.37 billion by 2034, exhibiting a CAGR of 7.74% during the forecast period. North America dominated the animal intestinal health market with a 23.52% market share in 2025, driven by the widespread adoption of advanced feed additives, increasing demand for antibiotic-free animal production, and well-established commercial livestock farming.

Animal intestinal health products are designed to improve gut microbiota balance, nutrient absorption, immune function, digestive efficiency, and overall animal productivity. These solutions include probiotics, prebiotics, digestive enzymes, phytogenic additives, postbiotics, organic acids, and immunostimulants that support livestock, poultry, aquaculture, companion animals, and other species. Growing concerns regarding antimicrobial resistance and increasing demand for sustainable livestock production continue to accelerate market growth worldwide.

Market Definition and Scope

The animal intestinal health market includes feed additives and nutritional solutions that improve digestive performance, strengthen intestinal integrity, enhance feed conversion, and reduce disease-related production losses. These products are widely used across poultry, swine, cattle, aquaculture, equine, companion animals, and other livestock species.

The market covers various product classes, applications, animal types, product forms, ingredient sources, and end users. Increasing emphasis on preventive animal healthcare, improved nutrition, and reduced dependence on antibiotic growth promoters continues to expand the market globally.

Market Dynamics

Drivers

The growing global demand for meat, milk, eggs, and aquaculture products is one of the primary drivers of the animal intestinal health market. As livestock production continues to increase, producers are adopting gut-health solutions that improve feed utilization, nutrient absorption, immunity, and overall animal performance.

Another important growth driver is the increasing use of probiotics, digestive enzymes, postbiotics, and organic acids as alternatives to antibiotic growth promoters. These products help reduce disease risks, improve productivity, and support sustainable animal farming practices while meeting evolving regulatory requirements.

Trends

An emerging trend in the market is the increasing adoption of enzyme-based feed solutions. Feed enzymes improve digestion, increase nutrient availability, reduce feed wastage, and support intestinal balance, making them valuable tools for improving feed efficiency and lowering production costs.

Manufacturers are also introducing innovative nutritional solutions that combine enzymes with probiotics, vitamins, and other functional ingredients to enhance gut health and overall animal performance across poultry, livestock, aquaculture, and companion animals.

Restraints

The high cost of specialty gut-health additives remains one of the major restraints limiting broader market adoption. Products such as advanced probiotics, postbiotics, and enzyme formulations require specialized manufacturing, stability testing, and species-specific validation, increasing production costs.

Smaller livestock producers often face financial challenges in adopting premium gut-health products, particularly during periods of fluctuating feed costs and lower profit margins.

Market Opportunities

The growing adoption of probiotics and postbiotics in animal nutrition presents significant growth opportunities. These ingredients help maintain healthy gut microbiota, improve immune function, enhance feed conversion, and reduce the need for antibiotics across poultry, swine, cattle, aquaculture, and companion animals.

Continuous investment in microbiome research, next-generation feed additives, and species-specific nutritional solutions is expected to create new opportunities for manufacturers throughout the forecast period.

Market Challenges

One of the major challenges facing the market is the inconsistent field performance of certain gut-health products under different farming conditions. Product effectiveness often varies depending on animal species, feed composition, disease pressure, environmental conditions, and farm management practices.

In addition, manufacturers must continue investing in scientific validation, product stability, and return-on-investment studies to improve farmer confidence and encourage wider adoption of advanced intestinal health solutions.

Segmentation Analysis

By Product Class, probiotics dominated the market in 2025 due to their proven ability to improve gut microbiota balance, immunity, feed conversion, and disease resistance. Prebiotics are expected to register strong growth during the forecast period as demand for natural gut-health solutions continues increasing.

By Application, the feed efficiency segment accounted for the largest market share owing to the growing need to maximize nutrient utilization and reduce production costs. Gut barrier & immunity is projected to witness significant growth due to increasing emphasis on preventive animal healthcare.

By Animal Type, poultry remained the dominant segment because intensive poultry production relies heavily on gut integrity, disease prevention, and efficient feed conversion. Aquaculture is anticipated to record the fastest growth due to expanding seafood production worldwide.

By Product Form, dry powder and premix formulations led the market because they are easy to manufacture, transport, store, and incorporate into commercial feed production. Tablets and capsules are expected to experience healthy growth in companion animal applications.

By Source, microbial-derived ingredients dominated the market due to the extensive use of probiotics, postbiotics, yeast derivatives, and microbial enzymes. Plant-derived products are expected to gain increasing popularity as producers seek natural alternatives.

By End User, feed mills and integrators accounted for the largest market share because of their large-scale use of gut-health additives across commercial livestock production systems.

Regional Insights

North America remained the leading regional market with a valuation of USD 1.12 billion in 2025, supported by advanced livestock production systems, increasing demand for antibiotic-free meat, and widespread use of probiotics, enzymes, and organic acids in animal feed.

Europe continues to experience strong growth due to strict antimicrobial reduction policies, sustainable livestock production, and animal welfare regulations. Asia Pacific is witnessing substantial expansion driven by growing poultry, swine, dairy, and aquaculture industries in China, India, Japan, and other emerging economies. Meanwhile, Latin America and the Middle East & Africa are experiencing steady growth as livestock producers increasingly adopt feed additives to improve productivity and digestive health.

Competitive Landscape

The global animal intestinal health market is moderately consolidated, with major companies investing heavily in research, product innovation, and microbiome-based nutritional solutions. Leading market participants include Cargill Incorporated, DSM-Firmenich, Novozymes A/S, Evonik Industries AG, Kemin Industries, Inc., ADM, Alltech, International Flavors & Fragrances Inc. (IFF), Nutreco, and BASF SE. These companies continue expanding their product portfolios with probiotics, enzymes, postbiotics, phytogenic additives, and organic acids to strengthen their market presence.

Report Coverage

This report provides a comprehensive analysis of the global animal intestinal health market, covering market size for 2025, 2026, and 2034, market dynamics, growth drivers, trends, restraints, opportunities, challenges, segmentation by product class, application, animal type, product form, source, and end user, regional outlook, competitive landscape, key industry developments, major company profiles, and future market growth prospects.

Conclusion

The global animal intestinal health market is projected to grow from USD 4.76 billion in 2025 to USD 9.37 billion by 2034, driven by rising livestock production, increasing demand for antibiotic-free animal nutrition, and growing adoption of probiotics, enzymes, postbiotics, and other advanced gut-health solutions. Continued innovation in microbiome-based nutrition, preventive healthcare, and sustainable feed technologies will further support market expansion. As producers increasingly prioritize feed efficiency, digestive health, and animal welfare, the animal intestinal health market is expected to achieve stable long-term growth throughout the forecast period.

Segmentation By Product Class, Application, Animal Type, Product Form, Source, End User, and Region

By Product Class * Probiotics

• Prebiotics
• Phytogenics/Botanicals
• Organic Acids & Acidifiers
• Digestive Enzymes
• Immunostimulants/Gut Barrier Support Products
• Others

By Application * Feed Efficiency

• Diarrhea & Scours
• Enteric Pathogen Control
• Dysbiosis
• Weaning Stress
• Gut Barrier & Immunity
• Others

By Animal Type * Swine

• Poultry
• Bovine
• Equine
• Aquaculture
• Canine
• Others

By Product Form * Dry Powder/Premix

• Granules/Pellets
• Liquid
• Paste/Gel
• Tablets/Capsules
• Others

By Source * Microbial-Derived

• Plant-Derived
• Organic Acid/Chemical-Derived
• Others

By End User * Feed Mills & Integrators

• Livestock Producers/Farms
• Veterinary Clinics & Hospitals
• Pet Owners
• Aquaculture Producers
• Others

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends
• 3.5. Market Challenges

4. Key Insights

• 4.1. Statistics: Animal Population, By Key Species, Bye Countries/Region, 2025
• 4.2. New Product Launches, By Key Players
• 4.3. Overview of Regulatory Scenario, By Key Regions/ Countries
• 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)

5. Global Animal Intestinal Health Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Class
  • 5.1.1. Probiotics
  • 5.1.2. Prebiotics
  • 5.1.3. Phytogenics/Botanicals
  • 5.1.4. Organic Acids & Acidifiers
  • 5.1.5. Digestive Enzymes
  • 5.1.6. Immunostimulants/Gut Barrier Support Products
  • 5.1.7. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Feed Efficiency
  • 5.2.2. Diarrhea & Scours
  • 5.2.3. Enteric Pathogen Control
  • 5.2.4. Dysbiosis
  • 5.2.5. Weaning Stress
  • 5.2.6. Gut Barrier & Immunity
  • 5.2.7. Others
• 5.3. Market Analysis, Insights and Forecast - By Animal Type
  • 5.3.1. Swine
  • 5.3.2. Poultry
  • 5.3.3. Bovine
  • 5.3.4. Equine
  • 5.3.5. Aquaculture
  • 5.3.6. Canine
  • 5.3.7. Others
• 5.4. Market Analysis, Insights and Forecast - By Product Form
  • 5.4.1. Dry Powder/Premix
  • 5.4.2. Granules/Pellets
  • 5.4.3. Liquid
  • 5.4.4. Paste/Gel
  • 5.4.5. Tablets/Capsules
  • 5.4.6. Others
• 5.5. Market Analysis, Insights and Forecast - By Source
  • 5.5.1. Microbial-derived
  • 5.5.2. Plant-derived
  • 5.5.3. Organic Acid/Chemical-derived
  • 5.5.4. Others
• 5.6. Market Analysis, Insights and Forecast - By End User
  • 5.6.1. Feed Mills & Integrators
  • 5.6.2. Livestock Producers/Farms
  • 5.6.3. Veterinary Clinics & Hospitals
  • 5.6.4. Pet Owners
  • 5.6.5. Aquaculture Producers
  • 5.6.6. Others
• 5.7. Market Analysis, Insights and Forecast - Region
  • 5.7.1. North America
  • 5.7.2. Europe
  • 5.7.3. Asia Pacific
  • 5.7.4. Latin America
  • 5.7.5. Middle East & Africa

6. North America Animal Intestinal Health Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Class
  • 6.1.1. Probiotics
  • 6.1.2. Prebiotics
  • 6.1.3. Phytogenics/Botanicals
  • 6.1.4. Organic Acids & Acidifiers
  • 6.1.5. Digestive Enzymes
  • 6.1.6. Immunostimulants/Gut Barrier Support Products
  • 6.1.7. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Feed Efficiency
  • 6.2.2. Diarrhea & Scours
  • 6.2.3. Enteric Pathogen Control
  • 6.2.4. Dysbiosis
  • 6.2.5. Weaning Stress
  • 6.2.6. Gut Barrier & Immunity
  • 6.2.7. Others
• 6.3. Market Analysis, Insights and Forecast - By Animal Type
  • 6.3.1. Swine
  • 6.3.2. Poultry
  • 6.3.3. Bovine
  • 6.3.4. Equine
  • 6.3.5. Aquaculture
  • 6.3.6. Canine
  • 6.3.7. Others
• 6.4. Market Analysis, Insights and Forecast - By Product Form
  • 6.4.1. Dry Powder/Premix
  • 6.4.2. Granules/Pellets
  • 6.4.3. Liquid
  • 6.4.4. Paste/Gel
  • 6.4.5. Tablets/Capsules
  • 6.4.6. Others
• 6.5. Market Analysis, Insights and Forecast - By Source
  • 6.5.1. Microbial-derived
  • 6.5.2. Plant-derived
  • 6.5.3. Organic Acid/Chemical-derived
  • 6.5.4. Others
• 6.6. Market Analysis, Insights and Forecast - By End User
  • 6.6.1. Feed Mills & Integrators
  • 6.6.2. Livestock Producers/Farms
  • 6.6.3. Veterinary Clinics & Hospitals
  • 6.6.4. Pet Owners
  • 6.6.5. Aquaculture Producers
  • 6.6.6. Others
• 6.7. Market Analysis, Insights and Forecast - By Country
  • 6.7.1. U.S.
  • 6.7.2. Canada

7. Europe Animal Intestinal Health Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Class
  • 7.1.1. Probiotics
  • 7.1.2. Prebiotics
  • 7.1.3. Phytogenics/Botanicals
  • 7.1.4. Organic Acids & Acidifiers
  • 7.1.5. Digestive Enzymes
  • 7.1.6. Immunostimulants/Gut Barrier Support Products
  • 7.1.7. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Feed Efficiency
  • 7.2.2. Diarrhea & Scours
  • 7.2.3. Enteric Pathogen Control
  • 7.2.4. Dysbiosis
  • 7.2.5. Weaning Stress
  • 7.2.6. Gut Barrier & Immunity
  • 7.2.7. Others
• 7.3. Market Analysis, Insights and Forecast - By Animal Type
  • 7.3.1. Swine
  • 7.3.2. Poultry
  • 7.3.3. Bovine
  • 7.3.4. Equine
  • 7.3.5. Aquaculture
  • 7.3.6. Canine
  • 7.3.7. Others
• 7.4. Market Analysis, Insights and Forecast - By Product Form
  • 7.4.1. Dry Powder/Premix
  • 7.4.2. Granules/Pellets
  • 7.4.3. Liquid
  • 7.4.4. Paste/Gel
  • 7.4.5. Tablets/Capsules
  • 7.4.6. Others
• 7.5. Market Analysis, Insights and Forecast - By Source
  • 7.5.1. Microbial-derived
  • 7.5.2. Plant-derived
  • 7.5.3. Organic Acid/Chemical-derived
  • 7.5.4. Others
• 7.6. Market Analysis, Insights and Forecast - By End User
  • 7.6.1. Feed Mills & Integrators
  • 7.6.2. Livestock Producers/Farms
  • 7.6.3. Veterinary Clinics & Hospitals
  • 7.6.4. Pet Owners
  • 7.6.5. Aquaculture Producers
  • 7.6.6. Others
• 7.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.7.1. U.K.
  • 7.7.2. Germany
  • 7.7.3. France
  • 7.7.4. Italy
  • 7.7.5. Spain
  • 7.7.6. Scandinavia
  • 7.7.7. Rest of Europe

8. Asia Pacific Animal Intestinal Health Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Class
  • 8.1.1. Probiotics
  • 8.1.2. Prebiotics
  • 8.1.3. Phytogenics/Botanicals
  • 8.1.4. Organic Acids & Acidifiers
  • 8.1.5. Digestive Enzymes
  • 8.1.6. Immunostimulants/Gut Barrier Support Products
  • 8.1.7. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Feed Efficiency
  • 8.2.2. Diarrhea & Scours
  • 8.2.3. Enteric Pathogen Control
  • 8.2.4. Dysbiosis
  • 8.2.5. Weaning Stress
  • 8.2.6. Gut Barrier & Immunity
  • 8.2.7. Others
• 8.3. Market Analysis, Insights and Forecast - By Animal Type
  • 8.3.1. Swine
  • 8.3.2. Poultry
  • 8.3.3. Bovine
  • 8.3.4. Equine
  • 8.3.5. Aquaculture
  • 8.3.6. Canine
  • 8.3.7. Others
• 8.4. Market Analysis, Insights and Forecast - By Product Form
  • 8.4.1. Dry Powder/Premix
  • 8.4.2. Granules/Pellets
  • 8.4.3. Liquid
  • 8.4.4. Paste/Gel
  • 8.4.5. Tablets/Capsules
  • 8.4.6. Others
• 8.5. Market Analysis, Insights and Forecast - By Source
  • 8.5.1. Microbial-derived
  • 8.5.2. Plant-derived
  • 8.5.3. Organic Acid/Chemical-derived
  • 8.5.4. Others
• 8.6. Market Analysis, Insights and Forecast - By End User
  • 8.6.1. Feed Mills & Integrators
  • 8.6.2. Livestock Producers/Farms
  • 8.6.3. Veterinary Clinics & Hospitals
  • 8.6.4. Pet Owners
  • 8.6.5. Aquaculture Producers
  • 8.6.6. Others
• 8.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.7.1. China
  • 8.7.2. Japan
  • 8.7.3. India
  • 8.7.4. Southeast Asia
  • 8.7.5. Australia
  • 8.7.6. Rest of Asia Pacific

9. Latin America Animal Intestinal Health Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Class
  • 9.1.1. Probiotics
  • 9.1.2. Prebiotics
  • 9.1.3. Phytogenics/Botanicals
  • 9.1.4. Organic Acids & Acidifiers
  • 9.1.5. Digestive Enzymes
  • 9.1.6. Immunostimulants/Gut Barrier Support Products
  • 9.1.7. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Feed Efficiency
  • 9.2.2. Diarrhea & Scours
  • 9.2.3. Enteric Pathogen Control
  • 9.2.4. Dysbiosis
  • 9.2.5. Weaning Stress
  • 9.2.6. Gut Barrier & Immunity
  • 9.2.7. Others
• 9.3. Market Analysis, Insights and Forecast - By Animal Type
  • 9.3.1. Swine
  • 9.3.2. Poultry
  • 9.3.3. Bovine
  • 9.3.4. Equine
  • 9.3.5. Aquaculture
  • 9.3.6. Canine
  • 9.3.7. Others
• 9.4. Market Analysis, Insights and Forecast - By Product Form
  • 9.4.1. Dry Powder/Premix
  • 9.4.2. Granules/Pellets
  • 9.4.3. Liquid
  • 9.4.4. Paste/Gel
  • 9.4.5. Tablets/Capsules
  • 9.4.6. Others
• 9.5. Market Analysis, Insights and Forecast - By Source
  • 9.5.1. Microbial-derived
  • 9.5.2. Plant-derived
  • 9.5.3. Organic Acid/Chemical-derived
  • 9.5.4. Others
• 9.6. Market Analysis, Insights and Forecast - By End User
  • 9.6.1. Feed Mills & Integrators
  • 9.6.2. Livestock Producers/Farms
  • 9.6.3. Veterinary Clinics & Hospitals
  • 9.6.4. Pet Owners
  • 9.6.5. Aquaculture Producers
  • 9.6.6. Others
• 9.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.7.1. Brazil
  • 9.7.2. Mexico
  • 9.7.3. Rest of Latin America

10. Middle East & Africa Animal Intestinal Health Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Class
  • 10.1.1. Probiotics
  • 10.1.2. Prebiotics
  • 10.1.3. Phytogenics/Botanicals
  • 10.1.4. Organic Acids & Acidifiers
  • 10.1.5. Digestive Enzymes
  • 10.1.6. Immunostimulants/Gut Barrier Support Products
  • 10.1.7. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Feed Efficiency
  • 10.2.2. Diarrhea & Scours
  • 10.2.3. Enteric Pathogen Control
  • 10.2.4. Dysbiosis
  • 10.2.5. Weaning Stress
  • 10.2.6. Gut Barrier & Immunity
  • 10.2.7. Others
• 10.3. Market Analysis, Insights and Forecast - By Animal Type
  • 10.3.1. Swine
  • 10.3.2. Poultry
  • 10.3.3. Bovine
  • 10.3.4. Equine
  • 10.3.5. Aquaculture
  • 10.3.6. Canine
  • 10.3.7. Others
• 10.4. Market Analysis, Insights and Forecast - By Product Form
  • 10.4.1. Dry Powder/Premix
  • 10.4.2. Granules/Pellets
  • 10.4.3. Liquid
  • 10.4.4. Paste/Gel
  • 10.4.5. Tablets/Capsules
  • 10.4.6. Others
• 10.5. Market Analysis, Insights and Forecast - By Source
  • 10.5.1. Microbial-derived
  • 10.5.2. Plant-derived
  • 10.5.3. Organic Acid/Chemical-derived
  • 10.5.4. Others
• 10.6. Market Analysis, Insights and Forecast - By End User
  • 10.6.1. Feed Mills & Integrators
  • 10.6.2. Livestock Producers/Farms
  • 10.6.3. Veterinary Clinics & Hospitals
  • 10.6.4. Pet Owners
  • 10.6.5. Aquaculture Producers
  • 10.6.6. Others
• 10.7. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.7.1. GCC
  • 10.7.2. South Africa
  • 10.7.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Cargill, Incorporated
  • 11.2.2. dsm-firmenich
  • 11.2.3. Novozymes A/S
  • 11.2.4. Evonik Industries AG
  • 11.2.5. Kemin Industries, Inc.
  • 11.2.6. ADM
  • 11.2.7. Alltech
  • 11.2.8. International Flavors & Fragrances Inc.
  • 11.2.9. Nutreco
  • 11.2.10. BASF SE.